BELLEVUE, Wash.--(BUSINESS WIRE)--SCOLR Pharma, Inc. (AMEX: DDD) today announced today that the Company will present at the Roth Capital Partners 2007 New York Conference.
Daniel O. Wilds, SCOLR Pharma's President and CEO, is scheduled to present an overview of the Company's operations on Thursday, September 6, 2007 at 2:30 p.m. ET. The conference will be held at The Westin New York in New York City.
